Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal circulating purine concentration (HP:0004352)help
Parent Node:
expand
Azotemia (HP:0002157)help
Parent Node:
expand
Increased circulating purine concentration (HP:0004368)help
..Starting node
..expand
Hyperuricemia (HP:0002149)help
Term ID: 2149
Name: Hyperuricemia
Synonym: High blood uric acid level; Hyperuricaemia
Definition: An abnormally high level of uric acid in the blood.
Comments:
Reference: HP:0002149
Genes and Diseases:
 
       Child Nodes:
........expandGout (HP:0001997) help
................... HP:0001854 Podagra

 Sister Nodes: 
..expandExcessive purine production (HP:0003142) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002149HP:0002149Hyperuricemia0ACAT1 CL E G H3893ORPHA:134Beta-ketothiolase deficiencyHP:0040281 - Very frequent91
HP:0002149HP:0002149Hyperuricemia0ALDOB CL E G H229417OMIM:229600Fructose intolerance, hereditary.73
HP:0002149HP:0002149Hyperuricemia0ALDOB CL E G H229417ORPHA:469Hereditary fructose intoleranceHP:0040283 - Occasional73
HP:0002149HP:0002149Hyperuricemia0ALMS1 CL E G H7840428OMIM:203800Alstrom syndrome.404
HP:0002149HP:0002149Hyperuricemia0CLDN16 CL E G H106862037OMIM:248250Hypomagnesemia 3, renal.58
HP:0002149HP:0002149Hyperuricemia0FBP1 CL E G H22033606ORPHA:348Fructose-1,6-bisphosphatase deficiencyHP:0040282 - Frequent64
HP:0002149HP:0002149Hyperuricemia0G6PC1 CL E G H25384056OMIM:232200Glycogen storage disease ia.
HP:0002149HP:0002149Hyperuricemia0HMGCL CL E G H31555005ORPHA:203-hydroxy-3-methylglutaric aciduriaHP:0040282 - Frequent35
HP:0002149HP:0002149Hyperuricemia0HMGCL CL E G H31555005OMIM:2464503-Hydroxy-3-Methylglutaryl-Coa lyase deficiency.35
HP:0002149HP:0002149Hyperuricemia0HNF1B CL E G H692811630ORPHA:93111HNF1B-related autosomal dominant tubulointerstitial kidney diseaseHP:0040283 - Occasional90
HP:0002149HP:0002149Hyperuricemia0HNF1B CL E G H692811630OMIM:137920Renal cysts and diabetes syndrome90
HP:0002149HP:0002149Hyperuricemia0HPRT1 CL E G H32515157OMIM:300323Gout, hprt-related.76
HP:0002149HP:0002149Hyperuricemia0HPRT1 CL E G H32515157ORPHA:79233Hypoxanthine guanine phosphoribosyltransferase partial deficiencyHP:0040282 - Frequent76
HP:0002149HP:0002149Hyperuricemia0HPRT1 CL E G H32515157OMIM:300322Lesch-Nyhan syndrome.76
HP:0002149HP:0002149Hyperuricemia0HPRT1 CL E G H32515157ORPHA:510Lesch-Nyhan syndromeHP:0040281 - Very frequent76
HP:0002149HP:0002149Hyperuricemia0LMAN1 CL E G H39986631ORPHA:35909Combined deficiency of factor V and factor VIIIHP:0040284 - Very rare56
HP:0002149HP:0002149Hyperuricemia0MCFD2 CL E G H9041118451ORPHA:35909Combined deficiency of factor V and factor VIIIHP:0040284 - Very rare77
HP:0002149HP:0002149Hyperuricemia0MUC1 CL E G H45827508OMIM:174000Tubulointerstitial kidney disease, autosomal dominant, 2.1
HP:0002149HP:0002149Hyperuricemia0MYC CL E G H46097553ORPHA:543Burkitt lymphomaHP:0040282 - Frequent11
HP:0002149HP:0002149Hyperuricemia0PFKM CL E G H52138877ORPHA:371Glycogen storage disease due to muscle phosphofructokinase deficiencyHP:0040282 - Frequent64
HP:0002149HP:0002149Hyperuricemia0PFKM CL E G H52138877OMIM:232800Glycogen storage disease VII.64
HP:0002149HP:0002149Hyperuricemia0PHKA2 CL E G H52568926OMIM:306000Glycogen storage disease ixa54
HP:0002149HP:0002149Hyperuricemia0PHKB CL E G H52578927OMIM:261750Glycogen storage disease ixb101
HP:0002149HP:0002149Hyperuricemia0PPARG CL E G H54689236OMIM:604367Lipodystrophy, familial partial, type 3.42
HP:0002149HP:0002149Hyperuricemia0PPARG CL E G H54689236ORPHA:79083PPARG-related familial partial lipodystrophyHP:0040283 - Occasional42
HP:0002149HP:0002149Hyperuricemia0PRPS1 CL E G H56319462ORPHA:411536Mild phosphoribosylpyrophosphate synthetase superactivityHP:0040281 - Very frequent49
HP:0002149HP:0002149Hyperuricemia0PRPS1 CL E G H56319462OMIM:300661Phosphoribosylpyrophosphate synthetase superactivity49
HP:0002149HP:0002149Hyperuricemia0PRPS1 CL E G H56319462ORPHA:411543Severe phosphoribosylpyrophosphate synthetase superactivityHP:0040281 - Very frequent49
HP:0002149HP:0002149Hyperuricemia0PYGM CL E G H58379726OMIM:232600Glycogen storage disease V166
HP:0002149HP:0002149Hyperuricemia0REN CL E G H59729958OMIM:613092Hyperuricemic nephropathy, familial juvenile, 2.25
HP:0002149HP:0002149Hyperuricemia0SARS2 CL E G H5493817697OMIM:613845Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis syndrome.60
HP:0002149HP:0002149Hyperuricemia0SEC61A1 CL E G H2992718276OMIM:617056Tubulointerstitial kidney disease, autosomal dominant, 5.2
HP:0002149HP:0002149Hyperuricemia0SH2B1 CL E G H2597030417ORPHA:261222Distal 16p11.2 microdeletion syndromeHP:0040282 - Frequent
HP:0002149HP:0002149Hyperuricemia0SLC37A4 CL E G H25424061ORPHA:79259Glycogen storage disease due to glucose-6-phosphatase deficiency type IbHP:0040281 - Very frequent110
HP:0002149HP:0002149Hyperuricemia0SLC37A4 CL E G H25424061OMIM:232220Glycogen storage disease ib.110
HP:0002149HP:0002149Hyperuricemia0SLC37A4 CL E G H25424061OMIM:232240GLYCOGEN STORAGE DISEASE Ic.110
HP:0002149HP:0002149Hyperuricemia0TNFRSF11A CL E G H879211908ORPHA:2801Juvenile Paget diseaseHP:0040281 - Very frequent72
HP:0002149HP:0002149Hyperuricemia0TNFRSF11B CL E G H498211909ORPHA:2801Juvenile Paget diseaseHP:0040281 - Very frequent44
HP:0002149HP:0002149Hyperuricemia0TNFRSF11B CL E G H498211909OMIM:239000Paget disease of bone 5, juvenile-onset.44
HP:0002149HP:0002149Hyperuricemia0UMOD CL E G H736912559OMIM:162000Hyperuricemic nephropathy, familial juvenile, 1.66


Genes (27) :ACAT1 ALDOB ALMS1 CLDN16 FBP1 G6PC1 HMGCL HNF1B HPRT1 LMAN1 MCFD2 MUC1 MYC PFKM PHKA2 PHKB PPARG PRPS1 PYGM REN SARS2 SEC61A1 SH2B1 SLC37A4 TNFRSF11A TNFRSF11B UMOD

Diseases (38) :ORPHA:134 OMIM:229600 ORPHA:469 OMIM:203800 OMIM:248250 ORPHA:348 OMIM:232200 ORPHA:20 OMIM:246450 ORPHA:93111 OMIM:137920 OMIM:300323 ORPHA:79233 OMIM:300322 ORPHA:510 ORPHA:35909 OMIM:174000 ORPHA:543 ORPHA:371 OMIM:232800 OMIM:306000 OMIM:261750 OMIM:604367 ORPHA:79083 ORPHA:411536 OMIM:300661 ORPHA:411543 OMIM:232600 OMIM:613092 OMIM:613845 OMIM:617056 ORPHA:261222 ORPHA:79259 OMIM:232220 OMIM:232240 ORPHA:2801 OMIM:239000 OMIM:162000
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.